Advanced search
Publication Cover
Epigenomics Volume 4, 2012 - Issue 5
Submit an article Journal homepage
149
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Epigenetic Profile in Chronic Lymphocytic Leukemia using Methylation-Specific Multiplex Ligation-Dependent Probe Amplification

Ana M Cosialls1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Antonio F Santidrián1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Llorenç Coll-Mulet1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, Spain;2 Institut de Medicina Predictiva i Personalitzada del Càncer (IMPPC), Badalona, Barcelona, SpainView further author information
,
Daniel Iglesias-Serret1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Diana M González-Gironès1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Alba Pérez-Perarnau1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Camila Rubio-Patiño1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Eva González-Barca3 Departament d‘Hematologia Clínica, IDIBELL–Institut Català d‘Oncologia, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Esther Alonso4 Servei d‘Hematologia, IDIBELL–Hospital de Bellvitge, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
,
Gabriel Pons1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainView further author information
&
Joan Gil1 Departament de Ciències Fisiològiques II, Institut d‘Investigació Biomèdica de Bellvitge (IDIBELL)–Universitat de Barcelona, L‘Hospitalet de Llobregat, Barcelona, SpainCorrespondence[email protected]
View further author information
 show all
Pages 491-501 | Published online: 06 Nov 2012

References

  • Zenz T , MertensD, KuppersR, DohnerH, StilgenbauerS. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat. Rev. Cancer10(1) , 37–50 (2010).
  • Rodriguez-Paredes M , EstellerM. Cancer epigenetics reaches mainstream oncology. Nat. Med.17(3) , 330–339 (2011).
  • Esteller M . Epigenetics in cancer. N. Engl. J. Med.358(11) , 1148–1159 (2008).
  • Plass C , ByrdJC, RavalA, TannerSM, de la Chapelle A. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes. Br. J. Haematol.139(5) , 744–752 (2007).
  • Bennett LB , TaylorKH, ArthurGL, RahmatpanahFB, HooshmandSI, CaldwellCW. Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia. Epigenomics2(1) , 53–70 (2010).
  • Rush LJ , RavalA, FunchainPet al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 64(7) , 2424–2433 (2004).
  • Kanduri M , CahillN, GoranssonHet al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 115(2) , 296–305 (2010).
  • Tong WG , WierdaWG, LinEet al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 5(6) , 499–508 (2010).
  • Yu MK , BergoniaH, SzaboA, PhillipsJD. Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index. Leuk. Res.31(6) , 773–777 (2007).
  • Irving L , Mainou-FowlerT, ParkerA, IbbotsonRE, OscierDG, StrathdeeG. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics6(3) , 300–306 (2011).
  • Fabris S , BollatiV, AgnelliLet al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6(2) , 188–194 (2011).
  • Rahmatpanah FB , CarstensS, HooshmandSIet al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 1(1) , 39–61 (2009).
  • Raval A , TannerSM, ByrdJCet al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129(5) , 879–890 (2007).
  • Yu L , LiuC, VandeusenJet al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37(3) , 265–274 (2005).
  • Motiwala T , MajumderS, KutayHet al. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia. Clin. Cancer Res. 13(11) , 3174–3181 (2007).
  • Fulop Z , CsernusB, TimarB, SzepesiA, MatolcsyA. Microsatellite instability and hMLH1 promoter hypermethylation in Richter‘s transformation of chronic lymphocytic leukemia. Leukemia17(2) , 411–415 (2003).
  • Mikeska T , CandiloroIL, DobrovicA. The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics2(4) , 561–573 (2010).
  • Nygren AO , AmezianeN, DuarteHMet al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33(14) , e128 (2005).
  • Eberth S , SchneiderB, RosenwaldAet al. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma. BMC Cancer 10 , 517 (2010).
  • Rohrs S , DirksWG, MeyerCet al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. Mol. Cancer 8 , 86 (2009).
  • Leong KJ , WeiW, TannahillLAet al. Methylation profiling of rectal cancer identifies novel markers of early-stage disease. Br. J. Surg. 98(5) , 724–734 (2011).
  • Campas C , CosiallsAM, BarraganMet al. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells. Exp. Hematol. 34(12) , 1663–1669 (2006).
  • Iglesias-Serret D , PiqueM, BarraganMet al. Aspirin induces apoptosis in human leukemia cells independently of NF-κB and MAPKs through alteration of the Mcl-1/Noxa balance. Apoptosis 15(2) , 219–229 (2010).
  • Jeuken JW , CornelissenSJ, VriezenMet al. MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas. Lab. Invest. 87(10) , 1055–1065 (2007).
  • Clark SJ , HarrisonJ, PaulCL, FrommerM. High sensitivity mapping of methylated cytosines. Nucleic Acids Res.22(15) , 2990–2997 (1994).
  • Melki JR , VincentPC, ClarkSJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res.59(15) , 3730–3740 (1999).
  • Mayor R , CasadomeL, AzuaraDet al. Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br. J. Cancer 100(10) , 1534–1539 (2009).
  • Frommer M , McDonaldLE, MillarDSet al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89(5) , 1827–1831 (1992).
  • Katzenellenbogen RA , BaylinSB, HermanJG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood93(12) , 4347–4353 (1999).
  • Takahashi T , ShivapurkarN, ReddyJet al. DNA methylation profiles of lymphoid and hematopoietic malignancies. Clin. Cancer Res. 10(9) , 2928–2935 (2004).
  • Rossi D , CapelloD, GloghiniAet al. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 89(2) , 154–164 (2004).
  • Chim CS , FungTK, WongKF, LauJS, LiangR. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia. J. Hum. Genet.51(9) , 832–838 (2006).
  • Seeliger B , WilopS, OsiekaR, GalmO, JostE. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk. Lymphoma50(3) , 419–426 (2009).
  • Fernandez AF , AssenovY, Martin-SuberoJIet al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 22(2) , 407–419 (2012).
  • Martel V , GuerciA, HumbertJCet al. De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia. Br. J. Haematol.99(2) , 320–324 (1997).
  • Chim CS , FungTK, WongKF, LauJS, LawM, LiangR. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J. Clin. Pathol.59(9) , 921–926 (2006).
  • Taylor KH , KramerRS, DavisJWet al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res. 67(18) , 8511–8518 (2007).
  • Papageorgiou SG , LambropoulosS, PappaVet al. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. Am. J. Hematol. 82(9) , 824–825 (2007).
  • Issa JP , ZehnbauerBA, CivinCIet al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res. 56(5) , 973–977 (1996).
  • Toyota M , KopeckyKJ, ToyotaMO, JairKW, WillmanCL, IssaJP. Methylation profiling in acute myeloid leukemia. Blood97(9) , 2823–2829 (2001).
  • Garcia-Manero G , DanielJ, SmithTLet al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin. Cancer Res. 8(7) , 2217–2224 (2002).
  • Iwai M , KiyoiH, OzekiKet al. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia 19(8) , 1367–1375 (2005).
  • Pinyol M , CoboF, BeaSet al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin‘s lymphomas. Blood91(8) , 2977–2984 (1998).
  • Tsirigotis P , PappaV, LabropoulosSet al. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur. J. Haematol. 76(3) , 230–236 (2006).
  • Coll-Mulet L , SantidrianAF, CosiallsAMet al. Multiplex ligation-dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia. Br. J. Haematol. 142(5) , 793–801 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.